Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind Placebo-controlled Multicenter Randomized Clinical Trial to Assess Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

NCT05273619 is registered in ClinicalTrials.gov with Valenta Pharm JSC as lead sponsor.

NCT NCT05273619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05273619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind Placebo-controlled Multicenter Randomized Clinical Trial to Assess Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection
Lead sponsor
Valenta Pharm JSC
Phase
Phase 3
Overall status
Completed
Start date
May 23, 2022
Completion date
July 29, 2022
Enrollment
250 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory infection, common cold, influenza, human